Experimental Therapeutics in the Treatment of COVID-19 – Infection by SARS-CoV-2
In March 2020, INFARMED, I.P., published two documents «Guidelines for Access to Experimental Therapeutics in the treatment of COVID-19 – infection by SARS-CoV-2» and «Experimental Therapeutics in the treatment of COVID-19 – infection by SARS-CoV-2”, which are based on information available from the...
| Autor principal: | |
|---|---|
| Formato: | article |
| Idioma: | por |
| Publicado em: |
2020
|
| Texto completo: | https://doi.org/10.25756/rpf.v12i1-2.246 |
| País: | Portugal |
| Oai: | oai:ojs.farmacoterapia.pt:article/290 |